Medifacts Drives Innovation in Telemedicine

Rockville, MD

Medifacts International, Inc., has announced a new innovation in the use of telemedicine, T-SMBP (Telemonitoring Self Measured Blood Pressure).

T-SMBP allows for remote collection of blood pressure (BP) data from a subject’s home. Telemonitoring and telemedicine are actively being implemented through health care providers for general patient care, specifically in patients being treated for heart failure, diabetes, cancer, and hypertension. The transition and implementation of telemedicine in clinical trials provides many benefits to the conduct of the study.  The benefits of implementing T-SMBP include:

• electronic capture of BP data, which removes transcription errors

• reduction in the number of office visits required by the subject; and perhaps most importantly

• real-time access to the subjects’ BP data via study web portal, which allows for alert criteria process and real-time view of data trends and treatment effect.
  
  Over the past two years, Medifacts has worked with their partners and devoted key resources to advancing the design, implementation and execution of T-SMBP in clinical trials to enhance a solution that is both functional and cost-effective. Medifacts was able to access its real-time clinical trial Ambulatory Blood Pressure Monitoring (ABPM) experience to enhance its T-SMBP solution.
  
  Michael Woehler, Medifacts International’s President and Chief Executive Officer said:  "We are seeing a very positive reaction to our proactive approach regarding technologies, study designs, and timetables.  It’s important to our clients that we be innovative and driven toward more effective solutions.”
  
  

Medifacts will present best practices and case studies of effective implementation of T-SMBP in clinical trials at The Med-e-Tel 2010 Conference in Luxembourg, April 14-16, 2010.